Back to search

Current pharmacological treatments for nicotine dependence

Data up to Jan 2025

Published2003
Citations182
References75

Total Citations Per Year

Abstract

References (75)

The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire

1991 • 10,143 citations

Book Reviews

1995 • 2,946 citations

A Controlled Trial of Sustained-Release Bupropion, a Nicotine Patch, or Both for Smoking Cessation

1999 • 1,635 citations

A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation

1997 • 1,273 citations

Measures of abstinence in clinical trials: issues and recommendations

2003 • 1,037 citations

Smoking and Major Depression

1993 • 821 citations

Bupropion: a review of its mechanism of antidepressant activity.

1995 • 693 citations

Inhibition of monoamine oxidase B in the brains of smokers

1996 • 666 citations

The effectiveness of the nicotine patch for smoking cessation. A meta-analysis

1994 • 533 citations

Bupropion is a nicotinic antagonist.

2000 • 490 citations

Cellular and synaptic mechanisms of nicotine addiction

2002 • 430 citations

Brain monoamine oxidase A inhibition in cigarette smokers

1996 • 427 citations

Identification of the Nicotinic Receptor Subtypes Expressed on Dopaminergic Terminals in the Rat Striatum

2002 • 400 citations

Nortriptyline and Cognitive-Behavioral Therapy in the Treatment of Cigarette Smoking

1998 • 400 citations

Cellular mechanisms of nicotine addiction

2001 • 396 citations

Recent Advances in the Pharmacotherapy of Smoking

1999 • 385 citations

Sex differences in nicotine effects and self-administration: Review of human and animal evidence

1999 • 384 citations

Differential Desensitization and Distribution of Nicotinic Acetylcholine Receptor Subtypes in Midbrain Dopamine Areas

2003 • 363 citations

Nicotine Transdermal Patch and Atypical Antipsychotic Medications for Smoking Cessation in Schizophrenia

2000 • 354 citations

Nicotinic Receptors in the Brain Links between Molecular Biology and Behavior

2000 • 352 citations

Treatment of Tobacco Use and Dependence

2002 • 347 citations

Sustained-Release Bupropion for Pharmacologic Relapse Prevention after Smoking Cessation

2001 • 343 citations

The Agency for Health Care Policy and Research Smoking Cessation Clinical Practice Guideline

1996 • 318 citations

Epidemiology of tobacco use in the United States

2002 • 311 citations

Presynaptic Nicotinic Modulation of Dopamine Release in the Three Ascending Pathways Studied by In Vivo Microdialysis: Comparison of Naive and Chronic Nicotine‐Treated Rats

1997 • 288 citations

Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine.

1999 • 280 citations

Nicotine as a modulator of behavior: beyond the inverted U

2003 • 254 citations

Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone

1994 • 253 citations

Treating Tobacco Use and Dependence

2002 • 231 citations

The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice

2003 • 214 citations

A Randomized Trial of Nortriptyline for Smoking Cessation

1998 • 199 citations

Psychological Intervention and Antidepressant Treatment in Smoking Cessation

2002 • 192 citations

Pharmacogenetic investigation of smoking cessation treatment

2002 • 181 citations

Influencing cigarette smoking with nicotine antagonists

1973 • 178 citations

Neuronal nicotinic receptors: from structure to function

2001 • 174 citations

A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers*

1995 • 167 citations

Nicotine-mecamylamine treatment for smoking cessation: The role of pre-cessation therapy.

1998 • 161 citations

Antimicrobial peptides from animals: focus on invertebrates

2002 • 158 citations

Nicotine Inhaler and Nicotine Patch as a Combination Therapy for Smoking Cessation

2000 • 155 citations

Smoking cessation and gender: the influence of physiological, psychological, and behavioral factors.

1996 • 149 citations

Nicotine–mecamylamine treatment for smoking cessation: The role of pre-cessation therapy.

1998 • 141 citations

Selective Antagonism at Dopamine D3 Receptors Prevents Nicotine-Triggered Relapse to Nicotine-Seeking Behavior

2003 • 140 citations

Efficacy of acute administration of nicotine gum in relief of cue-provoked cigarette craving

2003 • 138 citations

Doxepin as an adjunct to smoking cessation: a double-blind pilot study

1989 • 111 citations

A randomized trial of naltrexone for smoking cessation

1999 • 106 citations

A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation

2003 • 104 citations

Naloxone Challenge in Smokers

1999 • 104 citations

Endogenous opioids and smoking: A review of progress and problems

1998 • 103 citations

The therapeutic potential of nicotinic acetylcholine receptor agonists for pain control

2001 • 102 citations

Naltrexone, smoking behaviour and cigarette withdrawal

1995 • 101 citations

Antidepressant pharmacotherapy helps some cigarette smokers more than others.

1999 • 98 citations

BACLOFEN ANTAGONIZES INTRAVENOUS SELF-ADMINISTRATION OF NICOTINE IN MICE AND RATS

2002 • 97 citations

The increasing recalcitrance of smokers in clinical trials II: Pharmacotherapy trials

2003 • 94 citations

A meta‐analysis of double‐blind placebo‐controlled trials of clonidine for smoking cessation

1991 • 92 citations

The future of smoking cessation therapy in the United States

1996 • 90 citations

The effects of fluoxetine combined with nicotine inhalers in smoking cessation‐a randomized trial

1999 • 90 citations

Multicenter trial of fluoxetine as an adjunct to behavioral smoking cessation treatment.

2002 • 87 citations

Nicotine patch and paroxetine for smoking cessation.

2000 • 87 citations

Antidepressant pharmacotherapy helps some cigarette smokers more than others.

1999 • 83 citations

Sensitivity to nicotine and brain nicotinic receptors are altered by chronic nicotine and mecamylamine infusion.

1994 • 80 citations

Naltrexone and nicotine patch in smoking cessation: A preliminary study

2003 • 75 citations

Is Clonidine an Effective Smoking Cessation Therapy?

1995 • 71 citations

The Agency for Health Care Policy and Research Smoking Cessation Clinical Practice Guideline

1996 • 66 citations

The future of smoking cessation therapy in the United States

1996 • 59 citations

Passive immunization against nicotine prevents nicotine alleviation of nicotine abstinence syndrome

2001 • 58 citations

The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.

2000 • 57 citations

Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking

2001 • 52 citations

Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking

2001 • 52 citations

Efficacy of buspirone in smoking cessation: A placebo-controlled trial*

1996 • 45 citations

Naltrexone treatment for alcoholics: Effect on cigarette smoking rates

2003 • 40 citations

Nicotinic receptor blockade therapy and smoking cessation

1991 • 35 citations

Clonidine for smoking cessation

1999 • 29 citations

Transdermal clonidine for smoking cessation: A double-blind randomized dose–response study.

1996 • 19 citations

Clonidine for smoking cessation.

1998 • 14 citations

GlaxoSmithKline takes legal action to block new controls on its smoking cessation drug

2003 • 2 citations

Cited By (0)

No citing papers found in database

Current pharmacological treatments for nicotine dependence (2003) – Trends in Pharmacological Sciences | Metascience Observatory Explorer